Du George, Qiu Liyou, Shen Ling, Sehgal Probhat, Shen Yun, Huang Dan, Letvin Norman L, Chen Zheng W
Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine, 835 S. Wocoltt, MC790, Chicago, IL 60612, USA.
J Immunol Methods. 2006 Jan 20;308(1-2):19-35. doi: 10.1016/j.jim.2005.09.009. Epub 2005 Nov 15.
Despite recent advances in measuring cellular immune responses, the quantitation of antigen-specific T cell clones in infections or diseases remains challenging. Here, we employed combined megaplex TCR isolation and SMART-based real-time quantitation methods to quantitate numerous antigen-specific T cell clones using limited amounts of specimens. The megaplex TCR isolation covered the repertoire comprised of recombinants from 24 Vbeta families and 13 Jbeta segments, and allowed us to isolate TCR VDJ clonotypic sequences from one or many PPD-specific IFNgamma-producing T cells that were purified by flow cytometry sorting. The SMART amplification technique was then validated for its capacity to proportionally enrich cellular TCR mRNA/cDNA for real-time quantitation of large numbers of T cell clones. SMART amplified cDNA was shown to maintain relative expression levels of TCR genes when compared to unamplified cDNA. While the SMART-based real-time quantitative PCR conferred a detection limit of 10(-5) to 10(-6) antigen-specific T cells, the clonotypic primers specifically amplified and quantitated the target clone TCR but discriminated other clones that differed by >or=2 bases in the DJ regions. Furthermore, the combined megaplex TCR isolation and SMART-based real-time quantiation methods allowed us to quantitate large numbers of PPD-specific IFNgamma-producing T cell clones using as few as 2 x 10(6) PBMC collected weekly after mycobacterial infection. This assay system may be useful for studies of antigen-specific T cell clones in tumors, autoimmune and infectious diseases.
尽管在测量细胞免疫反应方面取得了最新进展,但在感染或疾病中对抗原特异性T细胞克隆进行定量分析仍然具有挑战性。在此,我们采用了多重TCR分离和基于SMART的实时定量方法相结合的技术,以使用有限量的标本对抗原特异性T细胞克隆进行定量分析。多重TCR分离涵盖了由24个Vβ家族和13个Jβ片段的重组体组成的库,并使我们能够从通过流式细胞术分选纯化的一个或多个PPD特异性产生IFNγ的T细胞中分离TCR VDJ克隆型序列。然后验证了SMART扩增技术按比例富集细胞TCR mRNA/cDNA以对大量T细胞克隆进行实时定量的能力。与未扩增的cDNA相比,SMART扩增的cDNA显示出维持TCR基因的相对表达水平。虽然基于SMART的实时定量PCR检测限为10^(-5)至10^(-6)个抗原特异性T细胞,但克隆型引物特异性扩增并定量目标克隆TCR,但可区分在DJ区域相差≥2个碱基的其他克隆。此外,多重TCR分离和基于SMART的实时定量方法相结合,使我们能够使用结核分枝杆菌感染后每周收集的低至2×10^6个外周血单核细胞(PBMC)来定量大量PPD特异性产生IFNγ的T细胞克隆。该检测系统可能有助于研究肿瘤、自身免疫性疾病和感染性疾病中的抗原特异性T细胞克隆。